Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Kooby

Showing results (121-130 of 292) with videos related to

Pageof 30
Sort By:
Annals of Surgical Oncology|March 2, 2011
Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resectionShishir K Maithel, Ipek Coban, Peter J Kneuertz, et al.
Journal of Surgical Oncology|March 14, 2022
Surgical resection for adrenocortical carcinoma: Current trends affecting survivalMonali Shah, Rachel E NeMoyer, Richi Kashyap, et al.
Annals of Surgical Oncology|March 11, 2026
ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic AdenocarcinomaMihir M Shah, Parit T Mavani, Subir Goyal, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 6, 2012
Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysisSarah B Fisher, Sameer H Patel, David A Kooby, et al.
Journal of Surgical Oncology|August 9, 2016
Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trialLauren M Postlewait, Cecilia G Ethun, David A Kooby, et al.
Annals of Surgical Oncology|November 4, 2009
Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinomaCarrie K Chu, Ashley E Mazo, Michael Goodman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 9, 2020
Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinomaHannah Williams, Mohammad R Jajja, Salila S Hashmi, et al.
Journal of the American College of Surgeons|May 29, 2012
Laparoscopic distal pancreatectomy: trends and lessons learned through an 11-year experiencePeter J Kneuertz, Sameer H Patel, Carrie K Chu, et al.
Cancer|May 31, 2013
Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinomaMalcolm H Squires, Sarah B Fisher, Kevin E Fisher, et al.
The American Journal of Surgical Pathology|November 19, 2010
Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 casesNobuyuki Ohike, Grace E Kim, Takuma Tajiri, et al.
Pageof 30

Showing results (121-130 of 292) with videos related to

Sort By:
Pageof 30
Annals of Surgical Oncology|March 2, 2011
Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resectionShishir K Maithel, Ipek Coban, Peter J Kneuertz, et al.
Journal of Surgical Oncology|March 14, 2022
Surgical resection for adrenocortical carcinoma: Current trends affecting survivalMonali Shah, Rachel E NeMoyer, Richi Kashyap, et al.
Annals of Surgical Oncology|March 11, 2026
ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic AdenocarcinomaMihir M Shah, Parit T Mavani, Subir Goyal, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 6, 2012
Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysisSarah B Fisher, Sameer H Patel, David A Kooby, et al.
Journal of Surgical Oncology|August 9, 2016
Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trialLauren M Postlewait, Cecilia G Ethun, David A Kooby, et al.
Annals of Surgical Oncology|November 4, 2009
Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinomaCarrie K Chu, Ashley E Mazo, Michael Goodman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 9, 2020
Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinomaHannah Williams, Mohammad R Jajja, Salila S Hashmi, et al.
Journal of the American College of Surgeons|May 29, 2012
Laparoscopic distal pancreatectomy: trends and lessons learned through an 11-year experiencePeter J Kneuertz, Sameer H Patel, Carrie K Chu, et al.
Cancer|May 31, 2013
Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinomaMalcolm H Squires, Sarah B Fisher, Kevin E Fisher, et al.
The American Journal of Surgical Pathology|November 19, 2010
Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 casesNobuyuki Ohike, Grace E Kim, Takuma Tajiri, et al.
Pageof 30